Historical Stock Price
RDHL historical stock prices picture
Redhill Biopharma Ltd Ramat Gan (RDHL) has the following price history information. Looking back at RDHL historical stock prices for the last five trading days, on April 11, 2024, RDHL opened at $0.49, traded as high as $0.49 and as low as $0.45, and closed at $0.45. Trading volume was a total of 540.50K shares. On April 12, 2024, RDHL opened at $0.45, traded as high as $0.46 and as low as $0.42, and closed at $0.42. Trading volume was a total of 544.90K shares. On April 15, 2024, RDHL opened at $0.43, traded as high as $0.44 and as low as $0.40, and closed at $0.40. Trading volume was a total of 367.80K shares. On April 16, 2024, RDHL opened at $0.38, traded as high as $0.40 and as low as $0.30, and closed at $0.39. Trading volume was a total of 983.80K shares. On April 17, 2024, RDHL opened at $0.39, traded as high as $0.41 and as low as $0.39, and closed at $0.39. Trading volume was a total of 240.90K shares.

RDHL Historical Stock Prices By Date:

RDHL historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Redhill Biopharma Ltd Ramat Gan shares, starting with a $10,000 purchase of RDHL, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/22/2014
End date: 04/17/2024
Start price/share: $574.80
End price/share: $0.39
Dividends collected/share: $0.00
Total return: -99.93%
Average Annual Total Return: -51.86%
Starting investment: $10,000.00
Ending investment: $6.71
Years: 9.99
Date Open High Low Close Volume
04/11/2024 $0.49 $0.49 $0.45 $0.45 540.50K
04/12/2024 $0.45 $0.46 $0.42 $0.42 544.90K
04/15/2024 $0.43 $0.44 $0.40 $0.40 367.80K
04/16/2024 $0.38 $0.40 $0.30 $0.39 983.80K
04/17/2024 $0.39 $0.41 $0.39 $0.39 240.90K
RedHill Biopharma is a biopharmaceutical company that focuses on commercialization and development of proprietary drugs for gastrointestinal (GI) diseases. The ongoing development programs of Co.'s therapeutic candidates, most in late-stage clinical development, include: RHB-204, which is for the treatment of mycobacterium avium complex disease; RHB-104, which is an investigational drug intended to treat Crohn's disease; RHB-102 (Bekinda®), which is an investigational once-daily bi-modal extended-release oral formulation of ondansetron; and RHB-106, which is an investigational tablet intended for the preparation and cleansing of the GI tract prior to the performance of abdominal procedures.
Date Close
04/11/2024$0.45
04/12/2024$0.42
04/15/2024$0.40
04/16/2024$0.39
04/17/2024$0.39
RDHL is categorized under the Healthcare sector; below are some other companies in the same sector:

RDNT Historical Stock Prices
RDUS Historical Stock Prices
RDY Historical Stock Prices
REGN Historical Stock Prices
REPH Historical Stock Prices
RETA Historical Stock Prices
RGDO Historical Stock Prices
RGDX Historical Stock Prices
RGEN Historical Stock Prices
RGLS Historical Stock Prices

Email EnvelopeFree RDHL Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


RDHL Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.